Predose

Company Overview

Snapshot

Founded in January 2024 by Gary Schonberg, Predose operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its automated platform for precision drug dosing. In January 2025, Predose was recognized as one of nine Israeli startups selected to help the UK improve its healthcare system.

Business overview

Predose is developing an automated platform that leverages patient-specific data and cloud-based technology to customize individual drug-dosing regimens directly at the clinic. The software platform integrates drug-specific clinical knowledge into mechanistic models, utilizing patient-specific covariates to create personalized "virtual twins" and automating the end-to-end precision dosing workflow. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support, serving healthcare providers.

Strategic signal

In January 2025, Predose was selected as one of nine Israeli startups to collaborate with the UK on improving its healthcare system. This recognition validates Predose's innovative approach to precision dosing and signals strong international interest in its technology, positioning the company for potential market expansion and strategic partnerships within the global healthcare landscape.

Company Intelligence Q&A

When was Predose founded?

Predose was founded in January 2024.

Who is the founder of Predose?

Gary Schonberg is the founder of Predose.

What is Predose's primary focus?

Predose is developing an automated platform for precision drug dosing, leveraging patient-specific data and cloud-based technology to customize individual drug-dosing regimens at the clinic.

What is the employee size of Predose?

Predose currently has 1–10 employees.

What significant recognition did Predose receive in early 2025?

In January 2025, Predose was identified as one of nine Israeli startups selected to contribute to improving the UK's healthcare system.